Adastra Announces Lachlan McLeod As Interim CEO
15 Apr 2024 //
ACCESSWIRE
Adastra Holdings Announces Record Single Purchase Order For Over $1M
01 Mar 2024 //
ACCESSWIRE
Adastra Holdings Announces Change of Auditor
15 Dec 2023 //
ACCESSWIRE
Adastra Provides Update Following Growup Awards Victory as Brand of The Year
11 Oct 2023 //
ACCESSWIRE
Adastra Holdings Receives Dual Nominations at 2023 Growup Awards and Gala
24 Aug 2023 //
ACCESSWIRE
Adastra Holdings Reports Second Quarter Results
17 Aug 2023 //
ACCESSWIRE
Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly
30 May 2023 //
ACCESSWIRE
Adastra Labs Clarifies and Retracts Certain Disclosure Related to
03 Mar 2023 //
ACCESSWIRE
Adastra Receives HC Approval for Amendment to Include Cocaine Under License
22 Feb 2023 //
ACCESSWIRE
Leadership Update: Adastra Appoints Lachlan McLeod as CFO
14 Feb 2023 //
ACCESSWIRE
Adastra Completes Transaction to Terminate Legacy Supply Agreement
09 Feb 2023 //
ACCESSWIRE
Adastra Receives Controlled Substances Dealer`s License
31 Aug 2022 //
ACCESSWIRE
Adastra Signs Option to Terminate Legacy Supply Agreement to Streamline
30 Aug 2022 //
ACCESSWIRE
Adastra Holdings Reports Record Second Quarter Results
26 Aug 2022 //
ACCESSWIRE
Adastra Announces Positive Top-Line Data from Phase 1b Trial of Zotiraciclib
12 Jan 2021 //
PRNEWSWIRE
Adastra Expands to Provide BHO while Inking Terms with Phyto Extractions
23 Dec 2020 //
ACCESSWIRE
Adastra Expands to Provide BHO while Inking Terms with Phyto Extractions
23 Dec 2020 //
ACCESSWIRE
Adastra Signs LOI to Acquire Iconic Legacy Market Phyto Extractions Brands
18 Sep 2020 //
BIOSPACE
Adastra Pharmaceuticals to Present at LifeSci Partners` Summer Symposium
28 Jul 2020 //
PRNEWSWIRE
Adastra Pharmaceuticals to Present at LifeSci Partners` Summer Symposium
27 Jul 2020 //
PRNEWSWIRE